Literature DB >> 21454404

The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling.

Tingting Li1, Sam R Holmstrom, Serkan Kir, Michihisa Umetani, Daniel R Schmidt, Steven A Kliewer, David J Mangelsdorf.   

Abstract

TGR5 is a G protein-coupled bile acid receptor present in brown adipose tissue and intestine, where its agonism increases energy expenditure and lowers blood glucose. Thus, it is an attractive drug target for treating human metabolic disease. However, TGR5 is also highly expressed in gallbladder, where its functions are less well characterized. Here, we demonstrate that TGR5 stimulates the filling of the gallbladder with bile. Gallbladder volume was increased in wild-type but not Tgr5(-/-) mice by administration of either the naturally occurring TGR5 agonist, lithocholic acid, or the synthetic TGR5 agonist, INT-777. These effects were independent of fibroblast growth factor 15, an enteric hormone previously shown to stimulate gallbladder filling. Ex vivo analyses using gallbladder tissue showed that TGR5 activation increased cAMP concentrations and caused smooth muscle relaxation in a TGR5-dependent manner. These data reveal a novel, gallbladder-intrinsic mechanism for regulating gallbladder contractility. They further suggest that TGR5 agonists should be assessed for effects on human gallbladder as they are developed for treating metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454404      PMCID: PMC3100601          DOI: 10.1210/me.2010-0460

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  21 in total

1.  Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

Authors:  T Lundåsen; C Gälman; B Angelin; M Rudling
Journal:  J Intern Med       Date:  2006-12       Impact factor: 8.989

2.  Identification of a hormonal basis for gallbladder filling.

Authors:  Mihwa Choi; Antonio Moschetta; Angie L Bookout; Li Peng; Michihisa Umetani; Sam R Holmstrom; Kelly Suino-Powell; H Eric Xu; James A Richardson; Robert D Gerard; David J Mangelsdorf; Steven A Kliewer
Journal:  Nat Med       Date:  2006-10-29       Impact factor: 53.440

3.  Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation.

Authors:  Galya Vassileva; Andrei Golovko; Lisa Markowitz; Susan J Abbondanzo; Ming Zeng; Shijun Yang; Lizbeth Hoos; Glen Tetzloff; Diane Levitan; Nicholas J Murgolo; Kevin Keane; Harry R Davis; Joseph Hedrick; Eric L Gustafson
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

4.  Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels.

Authors:  Brigitte Lavoie; Onesmo B Balemba; Cody Godfrey; Conall A Watson; Galya Vassileva; Carlos U Corvera; Mark T Nelson; Gary M Mawe
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

5.  Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4.

Authors:  C Yu; F Wang; M Kan; C Jin; R B Jones; M Weinstein; C X Deng; W L McKeehan
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

6.  Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice.

Authors:  Takaharu Maruyama; Kenichi Tanaka; Jun Suzuki; Hiroyuki Miyoshi; Naomoto Harada; Takao Nakamura; Yasuhisa Miyamoto; Akio Kanatani; Yoshitaka Tamai
Journal:  J Endocrinol       Date:  2006-10       Impact factor: 4.286

7.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

Authors:  Takeshi Inagaki; Mihwa Choi; Antonio Moschetta; Li Peng; Carolyn L Cummins; Jeffrey G McDonald; Guizhen Luo; Stacey A Jones; Bryan Goodwin; James A Richardson; Robert D Gerard; Joyce J Repa; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2005-10       Impact factor: 27.287

8.  Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Chikage Mataki; Marcelo A Christoffolete; Brian W Kim; Hiroyuki Sato; Nadia Messaddeq; John W Harney; Osamu Ezaki; Tatsuhiko Kodama; Kristina Schoonjans; Antonio C Bianco; Johan Auwerx
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

9.  Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho.

Authors:  Shinji Ito; Toshihiko Fujimori; Akiko Furuya; Junko Satoh; Yoko Nabeshima; Yo-Ichi Nabeshima
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

10.  A G protein-coupled receptor responsive to bile acids.

Authors:  Yuji Kawamata; Ryo Fujii; Masaki Hosoya; Masataka Harada; Hiromi Yoshida; Masanori Miwa; Shoji Fukusumi; Yugo Habata; Takashi Itoh; Yasushi Shintani; Shuji Hinuma; Yukio Fujisawa; Masahiko Fujino
Journal:  J Biol Chem       Date:  2003-01-10       Impact factor: 5.157

View more
  83 in total

1.  TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Authors:  Alessia Perino; Thijs Willem Hendrik Pols; Mitsunori Nomura; Sokrates Stein; Roberto Pellicciari; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 2.  Role of bile acids in the regulation of the metabolic pathways.

Authors:  Hiroki Taoka; Yoko Yokoyama; Kohkichi Morimoto; Naho Kitamura; Tatsuya Tanigaki; Yoko Takashina; Kazuo Tsubota; Mitsuhiro Watanabe
Journal:  World J Diabetes       Date:  2016-07-10

3.  Berberine-induced Inactivation of Signal Transducer and Activator of Transcription 5 Signaling Promotes Male-specific Expression of a Bile Acid Uptake Transporter.

Authors:  Pengli Bu; Yuan Le; Yue Zhang; Youcai Zhang; Xingguo Cheng
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

Review 4.  Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment.

Authors:  Karolina E Zaborska; Bethany P Cummings
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

5.  Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway.

Authors:  Senthilkumar Rajagopal; Divya P Kumar; Sunila Mahavadi; Sayak Bhattacharya; Ruizhe Zhou; Carlos U Corvera; Nigel W Bunnett; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-28       Impact factor: 4.052

Review 6.  Therapeutic targets for cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  Expert Opin Ther Targets       Date:  2015-10-19       Impact factor: 6.902

Review 7.  GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation.

Authors:  T Lieu; G Jayaweera; N W Bunnett
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 8.  Fighting obesity by targeting factors regulating beige adipocytes.

Authors:  Allison E McQueen; Suneil K Koliwad; Jen-Chywan Wang
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2018-11       Impact factor: 4.294

9.  The TGR5 receptor mediates bile acid-induced itch and analgesia.

Authors:  Farzad Alemi; Edwin Kwon; Daniel P Poole; TinaMarie Lieu; Victoria Lyo; Fiore Cattaruzza; Ferda Cevikbas; Martin Steinhoff; Romina Nassini; Serena Materazzi; Raquel Guerrero-Alba; Eduardo Valdez-Morales; Graeme S Cottrell; Kristina Schoonjans; Pierangelo Geppetti; Stephen J Vanner; Nigel W Bunnett; Carlos U Corvera
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

10.  Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.

Authors:  C Ullmer; R Alvarez Sanchez; U Sprecher; S Raab; P Mattei; H Dehmlow; S Sewing; A Iglesias; J Beauchamp; K Conde-Knape
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.